Codoxime: Difference between revisions
Appearance
Content deleted Content added
Nikos 1993 (talk | contribs) No edit summary |
No edit summary |
||
Line 48: | Line 48: | ||
==References== |
==References== |
||
{{reflist}} |
{{reflist}} |
||
{{Opioids}} |
|||
[[Category:Opioids]] |
|||
[[Category:Antitussives]] |
[[Category:Antitussives]] |
Revision as of 13:20, 20 October 2012
![]() | |
Clinical data | |
---|---|
Other names | Codoxime |
ATC code |
|
Legal status | |
Legal status | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ECHA InfoCard | 100.027.660 |
Chemical and physical data | |
Formula | C20H24N2O5 |
Molar mass | 372.415 g/mol g·mol−1 |
3D model (JSmol) | |
|
Codoxime (Codossima) is an opiate analogue that is a derivative of hydrocodone, where the 6-ketone group has been replaced by carboxymethyloxime. It has primarily antitussive effects[1] and was found to have moderate potential to cause dependence in animal studies.[2]
References
- ^ Jack Fishman. Morphinone and Codeinone Derivatives. US Patent 3153042
- ^ Jasinski DR, Martin WR. Assessment of the dependence-producing properties of dihydrocodeinone and codoxime. Clinical Pharmacology and Therapeutics. 1967 Mar-Apr;8(2):266-70. PMID 6021586